You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Portland (1)

Rehovot (1)

Condition

Adrenomyeloneuropathy (1)

Hypercholesterolemia (1)

Monocarboxylate Transporter 8 Deficiency (1)

X-Linked Adrenoleukodystrophy (1)

Overall Status

Recruiting (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Johns Hopkins University (1)

Kaplan Medical Center (1)

Thomas S. Scanlan (1)

Collaborator

Weizmann Institute of Science (1)

Intervention

3,5-diiodothyropropionic acid (ditpa) therapy (1)

glycerol phenylbutyrate 1100 mg/ml (1)

sobetirome (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

thyromimetic

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Monocarboxylate Transporter 8 Deficiency Trial in Rehovot (Glycerol Phenylbutyrate 1100 MG/ML)

Recruiting

Monocarboxylate Transporter 8 Deficiency

Glycerol Phenylbutyrate 1100 MG/ML

Rehovot, Israel

Pediatric Endocrinology Unit, Kapan Medical Center

Aug 22, 2021

X-Linked Adrenoleukodystrophy, Adrenomyeloneuropathy Trial in Portland (Sobetirome)

Withdrawn

X-Linked Adrenoleukodystrophy
Adrenomyeloneuropathy

Sobetirome

Portland, Oregon

Oregon Health & Science University

Feb 12, 2014

Hypercholesterolemia Trial in Baltimore (3,5-Diiodothyropropionic acid (DITPA) therapy)

Terminated

Hypercholesterolemia

3,5-Diiodothyropropionic acid (DITPA) therapy

Baltimore, Maryland

Johns Hopkins Bayview Medical Center

Apr 1, 2013